A detailed history of Formidable Asset Management, LLC transactions in Novartis Ag stock. As of the latest transaction made, Formidable Asset Management, LLC holds 3,265 shares of NVS stock, worth $321,112. This represents 0.06% of its overall portfolio holdings.

Number of Shares
3,265
Previous 3,767 13.33%
Holding current value
$321,112
Previous $401,000 6.48%
% of portfolio
0.06%
Previous 0.07%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$106.13 - $120.89 $53,277 - $60,686
-502 Reduced 13.33%
3,265 $375,000
Q2 2024

Aug 08, 2024

BUY
$92.57 - $107.37 $9,349 - $10,844
101 Added 2.76%
3,767 $401,000
Q1 2024

May 15, 2024

BUY
$95.27 - $108.47 $28,581 - $32,541
300 Added 8.91%
3,666 $354,000
Q4 2023

Feb 07, 2024

BUY
$92.27 - $101.54 $310,580 - $341,783
3,366 New
3,366 $339,000
Q4 2022

Feb 07, 2023

BUY
$75.55 - $92.52 $256,567 - $314,197
3,396 New
3,396 $308,000
Q2 2022

Aug 16, 2022

SELL
$80.52 - $93.75 $273,445 - $318,375
-3,396 Closed
0 $0
Q1 2022

May 04, 2022

BUY
$80.11 - $90.62 $272,053 - $307,745
3,396 New
3,396 $298,000
Q4 2021

Feb 07, 2022

SELL
$79.7 - $88.13 $279,189 - $308,719
-3,503 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$85.24 - $94.15 $292,202 - $322,746
3,428 Added 4570.67%
3,503 $321,000
Q2 2021

Aug 06, 2021

SELL
$85.24 - $94.15 $307,375 - $339,504
-3,606 Reduced 97.96%
75 $317,000
Q3 2020

Nov 13, 2020

BUY
$82.14 - $91.0 $3,449 - $3,822
42 Added 1.15%
3,681 $322,000
Q2 2020

Aug 13, 2020

BUY
$80.93 - $91.1 $294,504 - $331,512
3,639 New
3,639 $320,000
Q4 2017

Feb 13, 2018

SELL
$72.33 - $77.64 $382,336 - $410,405
-5,286 Closed
0 $0
Q3 2017

Nov 13, 2017

BUY
$74.14 - $77.27 $391,904 - $408,449
5,286
5,286 $454,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Formidable Asset Management, LLC Portfolio

Follow Formidable Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Formidable Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Formidable Asset Management, LLC with notifications on news.